Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Immunovia AB (publ)

IMMVF

HealthcareOTCSE

$0.02

$0.00 (+0.00%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

IMMVF

1Y0 (0.00%)

Candles, volume, SMA 20, and SMA 50

O 0.02H 0.02L 0.02C 0.02Date Jun 5

IMMVF

SMA 20 SMA 50 Vol 325EEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$6.11M

Volume?325

Avg Volume?89.1

52w Range$0.02 - $0.15

Beta?0.95

Price Performance

0.0%

$0.02 to $0.02

YTD

0.0%